U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07689162) titled 'Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia' on June 30.
Brief Summary: The purpose of our study is to find out which pain medication is more effective in reducing pain after nose surgery(rhinoplasty). We are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Pain, Postoperative
Intervention:
DRUG: Standard Bupivacaine
Volume: 4 mL of 0.75% bupivacaine hydrochloride
DRUG: Liposomal Bupivacaine
Volume: 1.5 mL of 0.75% bupivacaine hydrochloride and 2.5 mL of ...